A Drug-drug Interaction (DDI) Study of Morphothiadine Mesilate/Ritonavir in Healthy Subjects
Status:
Completed
Trial end date:
2019-06-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the drug-drug-interaction (DDI), pharmacokinetics
(PK) and tolerability of Morphothiadine Mesilate/Ritonavir combined with Entecavir or
Tenofovir Disoproxil Fumarate in healthy subjects